Overview
Investment Type
Venture Capital
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jun 26, 2013 | Mevion Medical Systems Secures $55M in Funding | Mevion Medical Systems, Inc., a Boston, MA-based provider of single-room proton therapy systems for the treatment of cancer, secured $55m in funding. Backers included existing investors Caxton Heath Life Sciences, ProQuest Investments, Venr... |
| Feb 1, 2012 | Telormedix elected member of multi-million collaborative research programme | |
| Jan 25, 2012 | Mevion Medical Systems Grabs Whopping $45M | LITTLETON, MA, Proton therapy company closed a $45M investment from ProQuest Investments and its existing investors, including Caxton Heath Life Sciences, Venrock and CHL Medical Partners. >> Click here for more funding data on Mev... |
| Jan 25, 2012 | Telormedix Secures Further Funding | |
| Jan 25, 2012 | Mevion Medical Systems Closes $45M Funding | Mevion Medical Systems, Inc. (formerly known as Still River Systems, Inc.) a Littleton, MA-based radiation therapy company dedicated to advancing the treatment of cancer, has closed a $45m funding. Backers include ProQuest Investments and e... |
| Jan 10, 2012 | Telormedix Raises CHF7.5M | Telormedix, a Bioggio, Switzerland-based clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and inflammatory diseases, has raised CHF7.5m in equity funding. Backers include existing investors Aravis... |
| Jun 16, 2010 | Predictive Biosciences Closes $25 million Series C round | Predictive Biosciences completed a $25 million Series C round, saying it plans to use the money to complete clinical trials for its CertNDx bladder cancer assay and ready it for market. The assay reduces the need to expensive and invasive c... |
| Jun 8, 2009 | Lead Therapeutics captures $3M for cancer treatments | Lead Therapeutics, developer of medications for cancer and other infectious diseases, has roped $3 million of an expected $7 million round of debt and rights, reports VentureWire. Based in San Bruno, Calif., it previously brought in $17 mil... |
| Apr 8, 2009 | Aerovance inhales $38M for asthma drugs | Aerovance, developer of asthma medications, just brought in $38 million in a post-recapitalized third round of funding to push its lead drug candidate through a second phase of clinical trials. The company has already received $20 million, ... |
Show more
Reviews 0
FAQ about ProQuest Investments
What has the press written about ProQuest Investments?
Parsers VC has collected 13 articles mentioning ProQuest Investments, among them “Mevion Medical Systems Secures $55M in Funding” (Jun 26, 2013) and “Telormedix elected member of multi-million collaborative research programme” (Feb 1, 2012).
Is ProQuest Investments still active?
ProQuest Investments is probably closed: its latest activity on Parsers VC dates from Dec 2, 2013.